EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Aberrant neutrophil and complement activation in thrombotic microangiopathies in pregnancy - Is there a missing link?

Maria Zaimi, Konstantinos Kambas, Smaragdi Marinaki, Marianna Theodora, Georgios Daskalakis, Eleni Frangou

Autoimmunity Reviews · 2026

DOI: 10.1016/j.autrev.2026.104151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Autoimmunity Reviews, 2026. Verfasst von Maria Zaimi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Alexandra Hospital, Athens, Greece; Department of Nephrology, National and Kapodistrian University of Athens Medical…. Hauptthemen laut MEDLINE: Complement Activation, Thrombotic Microangiopathies, Neutrophils, Neutrophil Activation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 208 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnancy-related acute kidney injury is a major global health burden associated with increased maternal and fetal morbidity and mortality. Thrombotic microangiopathies (TMA) occurring in pregnancy or postpartum include severe preeclampsia/Hemolysis Elevated Liver Enzymes Low Platelets (HELLP) syndrome, atypical Hemolytic Uremic Syndrome (aHUS) and Thrombotic Thrombocytopenic Purpura (TTP). Severe acute kidney injury and progression to chronic kidney disease are particularly associated with complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome and may also complicate severe preeclampsia/HELLP syndrome, while renal involvement is usually less prominent in TTP. Interestingly, preeclampsia, HELLP syndrome, aHUS, TTP, lupus nephritis and antiphospholipid syndrome share common autoimmune pathogenic mechanisms, as both are characterized by exaggerated neutrophil activation and increased neutrophil extracellular traps (NETs) release, as well as complement activation. In an era of targeted therapies, the lack of treatment of preeclampsia and HELLP results from the limited understanding of the underlying pathogenetic mechanisms. Eculizumab, a C5 inhibitor that targets the complement, significantly reduced the risk of ESKD in women with pregnancy-associated aHUS, supporting the therapeutic relevance of complement modulation. In this review, we performed a narrative synthesis of established and emerging experimental, translational and clinical data on pregnancy-associated TMAs, summarizing current evidence on the interaction between neutrophil dysregulation, NET formation, complement activation and endothelial injury in pregnancy-associated thrombotic microangiopathies. A better understanding of the neutrophil-NET-complement axis may help refine diagnostic distinctions among overlapping pregnancy-associated thrombotic microangiopathies and facilitate the development of more targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement ActivationThrombotic MicroangiopathiesNeutrophilsNeutrophil ActivationHumansFemalePregnancyHELLP SyndromeAnimalsPre-EclampsiaExtracellular Traps

Stichwörter der Autor:innen

Atypical hemolytic uremic syndromeComplementComplement inhibitionHELLP syndromeNeutrophil extracellular trapsPreeclampsiaThrombotic microangiopathy

Autor:innen und Institutionen

  • Department of Internal Medicine, Alexandra Hospital, Athens, Greece; Department of Nephrology, National and Kapodistrian University of Athens Medical School, Areteio Hospital, Athens, Greece.
  • Laboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.
  • Clinic of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens Medical School, Laiko Hospital, Athens, Greece.
  • Department of Obstetrics and Gynecology, Alexandra Hospital, Athens, Greece.
  • Department of Nephrology, National and Kapodistrian University of Athens Medical School, Areteio Hospital, Athens, Greece; Department of Nephrology, Limassol General Hospital, State Health Services Organization, Limasso…

Zitieren

APA

Zaimi, M., Kambas, K., Marinaki, S., Theodora, M., Daskalakis, G., & Frangou, E. (2026). Aberrant neutrophil and complement activation in thrombotic microangiopathies in pregnancy - Is there a missing link?. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2026.104151

Vancouver

Zaimi M, Kambas K, Marinaki S, Theodora M, Daskalakis G, Frangou E. Aberrant neutrophil and complement activation in thrombotic microangiopathies in pregnancy - Is there a missing link?. Autoimmunity Reviews. 2026. doi:10.1016/j.autrev.2026.104151

BibTeX
@article{Zaimi2026,
  author = {Zaimi, Maria and Kambas, Konstantinos and Marinaki, Smaragdi and Theodora, Marianna and Daskalakis, Georgios and Frangou, Eleni},
  title = {Aberrant neutrophil and complement activation in thrombotic microangiopathies in pregnancy - Is there a missing link?},
  journal = {Autoimmunity Reviews},
  year = {2026},
  doi = {10.1016/j.autrev.2026.104151}
}
Kostenlos starten →